By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Versartis, Inc.  

275 Shorline Drive
Suite 450
Redwood City  California  94065  U.S.A.
Phone: 650-963-8588 Fax: n/a



Start Up

Company News
Versartis, Inc. (VSAR) To Host Investor Symposium Featuring Global Opinion Leaders In Pediatric Human Growth Hormone Deficiency 8/11/2015 8:30:42 AM
Versartis, Inc. (VSAR) To Present At The Canaccord Genuity 35th Annual Growth Conference 8/5/2015 1:56:11 PM
Versartis, Inc. (VSAR) Abstract Accepted For Late-Breaker Presentation At The 54th Annual Meeting Of The European Society For Paediatric Endocrinology 8/4/2015 12:40:17 PM
Versartis, Inc. (VSAR) Reports Second Quarter 2015 Financial Results 8/4/2015 7:56:16 AM
Versartis, Inc. (VSAR) Announces Removal Of FDA Partial Clinical Hold And Continuation Of VRS-317 Phase III Clinical Trial 7/6/2015 7:10:09 AM
Versartis, Inc. (VSAR) To Present At The Bank of America (BAC) Merrill Lynch 2015 Health Care Conference 5/7/2015 12:24:40 PM
Versartis, Inc. (VSAR) Provides Update On Clinical Programs And Reports First Quarter 2015 Financial Results 5/7/2015 8:17:00 AM
Versartis, Inc. (VSAR) Appoints Jay Shepard As President And CEO 5/7/2015 6:06:48 AM
Versartis, Inc. (VSAR) Initiates Phase 2/3 Trial Of VRS-317 In Japan For Children With Growth Hormone Deficiency 4/13/2015 7:50:22 AM
Versartis, Inc. (VSAR) Presents 12-Month Data For VRS-317 At Late-Breaker Session At Endocrine Society's Annual Meeting 3/9/2015 8:01:50 AM